“This is a big step forward in this body of work - this is the data that the clinicians have been asking us to generate before we push into the clinic” commented PYC’s CEO Dr. Rohan Hockings.
Mmm… clinicians or potential partners?
Co-incidental that this announcement was released immediately following the Bio International Convention, which PYC attended again this year?
The Bio International Convention, which was held June 3-6, is the world’s largest gathering of the biotechnology industry.
Re: Ann: PMS Drug Candidate Effective, page-4
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
-0.005(4.35%) |
Mkt cap ! $513.2M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.8¢ | 11.0¢ | $297.5K | 2.621M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 1372418 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 390472 | 6 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |